Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
about
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive elementExpanding the clinical indications for α(1)-antitrypsin therapyRegulation of endothelial monocyte-activating polypeptide II release by apoptosisContext-Specific and Immune Cell-Dependent Antitumor Activities of α1-AntitrypsinInterleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblastsHypoxia-inducible factor-1alpha enhances haptoglobin gene expression by improving binding of STAT3 to the promoter.Serum proteomic changes after randomized prolonged erythropoietin treatment and/or endurance training: detection of novel biomarkers.The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational studyHypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factorHypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activityTumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cellsElevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer.Migraine associated with patent foramen ovale may be caused by reactivation of cerebral toxoplasmosis triggered by arterial blood oxygen desaturation.Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.Medical applications of Cu, Zn, and S isotope effects.Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.Effect of hyperbaric oxygenation on the regeneration of the liver after partial hepatectomy in rats.Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1.The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.Impact of plasma fibrinogen levels in benign and malignant soft tissue tumors.Revascularization of pancreatic islet allografts is enhanced by α-1-antitrypsin under anti-inflammatory conditions.Modulation of urinary peptidome in humans exposed to high altitude hypoxiaThe cross-sectional association between insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation (the CODAM study)
P2860
Q24316075-759D2A44-CC80-4B7C-8A42-3E8FB71D7FA8Q24528175-725AB2C5-1CAB-4BC5-BD9F-269C5D77498FQ27000764-FE8E0E76-F007-419B-A33E-299EE81C45ECQ28369078-8CF38927-DFC2-459E-86BA-D085BDB7CDACQ28817846-6993A446-D31D-4459-AEF0-9E69DD658C6AQ30894371-9DD2801F-AB13-460C-B796-0CDEF736A990Q34684790-D3F01B9A-B32C-4407-B332-0B9AB40293CAQ35560616-AAAACE46-3DDC-4199-887C-628F4344D5CFQ35678382-0688DA60-8B7A-406F-9AD7-85E79CDB0D89Q35900880-70C9BAD1-B9B6-4B71-8A0D-6F6BF457DDADQ36290085-A495E04F-5C8F-4272-97AE-2E243997E2E7Q36562473-A5567739-0BDF-420D-A609-6C2A04D8A5D0Q37072754-8FBB2AC3-6779-4701-A9B8-5311DDD23AD5Q37072929-FFB12E93-3CAB-4DDF-8734-5AE0B1E33099Q37202283-8B372AB4-E131-49E2-83C5-DDA72108F542Q37404757-3EEBB1C7-DF54-431C-8DE0-3A37C52D4D37Q37483472-35567E54-946E-44F4-93B5-4C81A6D213A2Q37701860-D0AD4E98-9E4F-4FE8-BE09-1B9FC3F76A88Q38165139-39D789C5-AD96-4B19-8443-CB3298150590Q38524496-963A0940-A260-4C58-A450-7C125E63AC57Q38924652-B51DCCDC-7A0C-46F2-AFEB-CF4F22140258Q39326693-C45740B8-B55A-4C66-AC19-6082C50C9F30Q41126616-FA13080C-B549-45E3-BBBE-DA6F03E0BFB7Q44992875-40C0471C-FCF6-4F55-A05C-A56A567BD650Q46505433-FFF427A3-72EE-4010-B342-B6364762C269Q47592974-B2D62C12-D963-4E0B-B261-71DCE21BEC45Q48058964-5201728C-0ED5-44C9-A1F3-40233F38F9C3Q53086754-1C6B014A-CC04-4264-937E-FBCC53552AABQ53125747-EF5CD41E-DCC5-4907-9B26-1012AE29E0D9Q53140685-EB5BC11C-DF1B-42D4-B264-AF68FEDBE24BQ57099063-BBFD491C-58BE-4AEA-A35E-4771D68DB27CQ57415496-440433D6-2477-4944-9E11-292A3A1946A1
P2860
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@ast
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@en
type
label
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@ast
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@en
prefLabel
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@ast
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@en
P2093
P356
P1476
Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line.
@en
P2093
P304
27865-27870
P356
10.1074/JBC.270.46.27865
P407
P577
1995-11-01T00:00:00Z